This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - Ph3 LEAP-012 Study

196 views
September 23, 2024
Comments 0
Login to view comments. Click here to Login